Inflammation and immunity in ovarian cancer

Inflammation and immunity in ovarian cancer

The standard first-line therapy for ovarian cancer is a combination of surgery and carboplatin/paclitaxel-based chemotherapy. Patients with longer survival and improved response to chemotherapy usually present T-cell inflamed tumours. The presence of tumour-infiltrating T cells (TILs) notably varies...

Full description

Bibliographic Details
Main Authors: Diego Salas-Benito, Enric Vercher, Enrique Conde, Javier Glez-Vaz, Ibon Tamayo, Sandra Hervas-Stubbs
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:EJC Supplements
Subjects:
Ovarian cancer
Immune response
Tumour immunosuppressive mechanisms
Tumour-associated antigens
Online Access:http://www.sciencedirect.com/science/article/pii/S135963492030001X

Internet

http://www.sciencedirect.com/science/article/pii/S135963492030001X

Similar Items